Similar articles for PMID: 27704226

Year	Number of Results
1996	1
1998	1
2001	1
2002	1
2004	3
2005	3
2006	1
2007	1
2008	1
2009	2
2010	5
2011	10
2012	5
2013	8
2014	7
2015	11
2016	13
2017	15
2018	12
2019	13
2020	17
2021	29
2022	26
2023	14
2024	0

1

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

Golshan M, Cirrincione CT, Sikov WM, Carey LA, Berry DA, Overmoyer B, Henry NL, Somlo G, Port E, Burstein HJ, Hudis C, Winer E, Ollila DW; Alliance for Clinical Trials in Oncology. Golshan M, et al. Breast Cancer Res Treat. 2016 Nov;160(2):297-304. doi: 10.1007/s10549-016-4006-6. Epub 2016 Oct 4. Breast Cancer Res Treat. 2016. PMID: 27704226 Free PMC article.

2

The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.

Yamaguchi T, Hozumi Y, Sagara Y, Takahashi M, Yoneyama K, Fujisawa T, Osumi S, Akabane H, Nishimura R, Mieno MN, Mukai H. Yamaguchi T, et al. Surg Oncol. 2021 Mar;36:51-55. doi: 10.1016/j.suronc.2020.11.008. Epub 2020 Nov 20. Surg Oncol. 2021. PMID: 33310293 Clinical Trial.

3

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

Golshan M, Cirrincione CT, Sikov WM, Berry DA, Jasinski S, Weisberg TF, Somlo G, Hudis C, Winer E, Ollila DW; Alliance for Clinical Trials in Oncology. Golshan M, et al. Ann Surg. 2015 Sep;262(3):434-9; discussion 438-9. doi: 10.1097/SLA.0000000000001417. Ann Surg. 2015. PMID: 26222764 Free PMC article. Clinical Trial.

4

Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.

Golshan M, Loibl S, Wong SM, Houber JB, O'Shaughnessy J, Rugo HS, Wolmark N, McKee MD, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE Jr, Sikov WM, Untch M. Golshan M, et al. JAMA Surg. 2020 Mar 1;155(3):e195410. doi: 10.1001/jamasurg.2019.5410. Epub 2020 Mar 18. JAMA Surg. 2020. PMID: 31913413 Free PMC article. Clinical Trial.

5

Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population.

Chang YK, Co M, Kwong A. Chang YK, et al. Breast Cancer. 2020 May;27(3):456-463. doi: 10.1007/s12282-019-01037-3. Epub 2020 Jan 8. Breast Cancer. 2020. PMID: 31916189

6

Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.

Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Swisher SK, et al. Ann Surg Oncol. 2016 Mar;23(3):749-56. doi: 10.1245/s10434-015-4921-5. Epub 2015 Oct 28. Ann Surg Oncol. 2016. PMID: 26511263

7

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.

Criscitiello C, Golshan M, Barry WT, Viale G, Wong S, Santangelo M, Curigliano G. Criscitiello C, et al. Eur J Cancer. 2018 Jul;97:1-6. doi: 10.1016/j.ejca.2018.03.023. Epub 2018 May 17. Eur J Cancer. 2018. PMID: 29734046

8

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).

Ollila DW, Cirrincione CT, Berry DA, Carey LA, Sikov WM, Hudis CA, Winer EP, Golshan M. Ollila DW, et al. J Am Coll Surg. 2017 Apr;224(4):688-694. doi: 10.1016/j.jamcollsurg.2016.12.036. Epub 2017 Jan 13. J Am Coll Surg. 2017. PMID: 28089784 Free PMC article.

9

Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study.

Kim HJ, Dominici L, Rosenberg SM, Zheng Y, Pak LM, Poorvu PD, Ruddy KJ, Tamimi R, Schapira L, Come SE, Peppercorn J, Borges VF, Warner E, Vardeh H, Collins LC, Gaither R, King TA, Partridge AH. Kim HJ, et al. Ann Surg. 2022 Jul 1;276(1):173-179. doi: 10.1097/SLA.0000000000004296. Epub 2020 Dec 23. Ann Surg. 2022. PMID: 33378304

10

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.

Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, Ross MI, Hunt KK. Newman LA, et al. Ann Surg Oncol. 2002 Apr;9(3):228-34. doi: 10.1007/BF02573059. Ann Surg Oncol. 2002. PMID: 11923128 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year